abstract |
A method of determining likelihood of acquiring drug resistance of a tumor or cancerous cells, cancer metastasis, cancer recurrence, or decreased life expectancy, comprising measuring the level of MUCl or MUCl-associated factor expressed in the cancerous cells or tumor. |